Knee replacement innovations in Asia Pacific With longer life expectancies in APAC, there is an… General surgery | Surgical device | Asia | General Surgery | Surgical Gateway | The Gateway
Cardiac biomarker testing market outlook in Asia-Pacific The incidence of cardiovascular diseases (CVD) in… In-vitro diagnostics | Point-of-care testing (POCT) | Asia | IVD Gateway | Point-of-care testing (POCT)
Cancer biomarker testing to grow in Asia The cancer burden in Asia is increasing, with new cancer… Cancer diagnostics | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Size and Share Plus | The Gateway
Japan: The age of orthopaedic robotics surgery Japan’s ageing population is catalysing the demand for… Uncategorised | Asia | General Surgery | Robotic surgery | Surgical Gateway | The Gateway
China’s wound surgery market outlook China’s wound closure market—covering synthetic… General surgery | Surgical device | Asia | China Segmentation Surgical Devices Tracker | Surgical Gateway | Surgical Procedure Volume Segmentation | The Gateway
China’s surgical advanced energy devices market outlook: wider VBP rollout and intensifying competition China’s advanced energy device market—covering… General surgery | Surgical device | Asia | China Segmentation Surgical Devices Tracker | Surgical Gateway | The Gateway
China surgery: City and hospital trends Gain an understanding of where the opportunities and… General surgery | Surgical device | Asia | China Segmentation Surgical Devices Tracker | Surgical Gateway | Surgical Procedure Volume Segmentation | The Gateway
China’s general surgery device market: government regulates pricing Recovery in surgery volume is driving market growth for… General surgery | Surgical device | Asia | China Segmentation Surgical Devices Tracker | Surgical Gateway | Surgical Procedure Volume Segmentation | The Gateway
Q2 2022 IVD China: point-of-care infectious-disease testing outperforms during the latest covid surge The impact of China’s latest covid-19 surge heads the… Centralised Diagnostics (CEDx) | Covid-19 testing | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Asia | Centralised Diagnostics (CEDx) | Covid-19 testing | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Tissue Diagnostics (TDx)
Outside of covid-19 diagnostics: Nine out of 16 APAC IVD markets have recovered to pre-pandemic levels Asia-Pacific (APAC) IVD markets have grown and exceeded… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx) | Asia | Centralised Diagnostics (CEDx) | Covid-19 testing | Infectious Diseases Testing Monitor | IVD Gateway | Molecular Diagnostics (MDx)
Most common cancer biomarkers for Europe NGS testing: RAS, BRAF, EGFR Most-commonly tested cancer biomarkers using NGS in Europe… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx) | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx)
Larger gene panels are the predominant NGS testing strategy in EU5 Larger gene panels are the predominant NGS testing strategy… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx) | Europe | IVD Gateway | LabPRO Plus | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Tissue Diagnostics (TDx)